Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
US10265302B2 · kind B2 · utility
0Cited by
1References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 29, 2018 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | Jan 29, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the compound of formula (I) for use in the treatment of a nonsense-mutation-mediated genetic disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.